Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
04:30pm, Friday, 24'th Apr 2026
LOS ANGELES, April 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Ho
MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop
03:24pm, Friday, 24'th Apr 2026
NEW YORK--(BUSINESS WIRE)---- $MEDP #BFA--Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop.
Medpace Holdings: Downgrade To 'Buy' As Revenue Growth Remains, But With Caution Ahead
03:14pm, Friday, 24'th Apr 2026
Medpace Holdings is downgraded from 'Strong Buy' to 'Buy' due to rising backlog cancellations and elevated direct costs, despite robust revenue growth. MEDP delivered Q1 2026 revenue of $706.6M (+26.5
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025
PACS or MEDP: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 24'th Apr 2026
Investors looking for stocks in the Medical Services sector might want to consider either PACS Group, Inc. (PACS) or Medpace (MEDP). But which of these two companies is the best option for those looki
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Friday, 24'th Apr 2026
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:20am, Friday, 24'th Apr 2026
LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medp
Down 15.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Medpace (MEDP)
10:35am, Friday, 24'th Apr 2026
The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
MEDP EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
09:53am, Friday, 24'th Apr 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired
Stock Market Today (LIVE): Meta Plugs Into Amazon's AI Chips; Intel Soars 25% on Earnings
09:43am, Friday, 24'th Apr 2026
Top insights from the latest market news from Friday, April 24, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Medpace Holdings, Inc. (MEDP) Q1 2026 Earnings Call Transcript
06:41pm, Thursday, 23'rd Apr 2026
Medpace Holdings, Inc. (MEDP) Q1 2026 Earnings Call Transcript
Medpace Flags Rising Cancellations, Near-Term Growth Uncertain
02:26pm, Thursday, 23'rd Apr 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) stock is trading lower on Thursday after the company reported its first-quarter earnings performance.
NEW YORK--(BUSINESS WIRE)---- $MEDP #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the �
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and Fe
Portnoy Law Firm Announces Class Action on Behalf of Medpace Holdings, Inc. Investors
09:00am, Thursday, 23'rd Apr 2026
LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace” or the "Company") (NASDAQ: MEDP) investors of a class action on behalf of investors
